XML 20 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 202,004 $ 436,189
Marketable securities available-for-sale 422,391 109,761
Accounts receivables, net 145,130 116,216
Other receivables 2,385 15,600
Inventories, net 59,446 61,335
Prepaid manufacturing 0 159,655
Prepaid expenses and other current assets 85,629 73,764
Total current assets 916,985 972,520
Property and equipment, net 37,596 35,020
Operating lease right-of-use assets 25,745 25,964
Goodwill 2,006 2,125
Restricted cash 207 219
Other assets 3,311 3,398
Total assets 985,850 1,039,246
Current liabilities:    
Accounts payable 3,211 2,600
Accrued research and development 4,775 4,688
CEPI accrual (Note 9) 107,738 128,848
Accrued liabilities (Note 7) 30,719 49,796
Warrant liability 0 18,016
Deferred revenue 0 349,864
Other current liabilities 3,631 2,590
Total current liabilities 150,074 556,402
Convertible Notes, net of debt discount of $3,922 and $5,010 at December 31, 2022 and December 31, 2021, respectively (Note 10) 221,578 220,490
Long-term portion of lease liabilities 32,801 34,316
Other long-term liabilities 384 5,664
Total liabilities 404,837 816,872
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Preferred stock: $0.001 par value, 5,000 shares authorized at December 31, 2022, and 2021; zero shares outstanding at December 31, 2022 and 2021 0 0
Common stock: $0.001 par value; 278,000 shares authorized at December 31, 2022, and 2021; 127,604 shares and 122,945 shares issued and outstanding at December 31, 2022 and 2021, respectively 128 123
Additional paid-in capital 1,510,518 1,441,868
Accumulated other comprehensive (loss) (5,438) (2,266)
Accumulated deficit (924,195) (1,217,351)
Total stockholders’ equity 581,013 222,374
Total liabilities and stockholders’ equity $ 985,850 $ 1,039,246